An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage

Cited by (1,002)

Items 101–200 of 1,002

1. Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC
   Bin Qiu, Wei Guo, Fan Zhang, Fang Lv, Ying Ji, Yue Peng, Xiaoxi Chen, Hua Bao, Yang Xu, Yang Washington Shao et al. · 2021 · Nature Communications
2. Circulating biomarkers for early detection and clinical management of colorectal cancer
   María Marcuello, Veronika Polakova Vymetalkova, Rui P. Neves, Saray Durán-Sanchón, Hege Marie Vedeld, Emma Tham, Guus van Dalum, Georg Flügen, Vanesa García‐Barberán, Remond J.A. Fijneman et al. · 2019 · Molecular Aspects of Medicine
3. An electrochemical clamp assay for direct, rapid analysis of circulating nucleic acids in serum
   Jagotamoy Das, Ivaylo Ivanov, Laura Montermini, Janusz W. Rak, Edward Hartley Sargent, Shana O. Kelley · 2015 · Nature Chemistry
4. Circulating Tumor DNA Analysis for Detection of Minimal Residual Disease After Chemoradiotherapy for Localized Esophageal Cancer
   Tej Deepak Azad, Aadel A. Chaudhuri, Penny Fang, Yawei Qiao, Mohammad Shahrokh Esfahani, Jacob J. Chabon, Emily G. Hamilton, Yi D. Yang, Alex Lovejoy, Aaron M. Newman et al. · 2019 · Gastroenterology
5. Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma
   Anne K. Krug, Daniel Enderle, Chris Karlovich, Tina Priewasser, Stefan Bentink, Alexandra Spiel, Kay Brinkmann, Jennifer Emenegger, D.G. Grimm, Elena Castellanos-Rizaldos et al. · 2017 · Annals of Oncology
6. Clinical Implications of Genomic Discoveries in Lung Cancer
   Charles Swanton, Ramaswamy Govindan · 2016 · New England Journal of Medicine
7. Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection
   Clare Fiala, Eleftherios P. Diamandis · 2018 · BMC Medicine
8. Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes
   Farshad Nassiri, Ankur Chakravarthy, Shengrui Feng, Shu Yi Shen, Romina Nejad, Jeffrey Zuccato, Mathew Ryan Voisin, Vikas S. Patil, Craig Horbinski, Kenneth Aldape et al. · 2020 · Nature Medicine
9. Circulating tumor DNA as a non‐invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types
   Ronald Lebofsky, Charles Decraene, Virginie Bernard, Maud T Kamal, Anthony Blin, Quentin Leroy, Thomas Rio Frio, Gaëlle Pierron, Céline Callens, Ivan Bièche et al. · 2014 · Molecular Oncology
10. Normal and Cancerous Tissues Release Extrachromosomal Circular DNA (eccDNA) into the Circulation
    Pankaj Kumar, Laura Williams Dillon, Yoshiyuki Shibata, Amir Anthony Jazaeri, David Randolph Jones, Anindya Dutta · 2017 · Molecular Cancer Research
11. Non-invasive diagnosis of early-stage lung cancer using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA)
    Wenhua Liang, Yue Zhao, Weizhe Huang, Yangbin Gao, Weihong Xu, Jinsheng Tao, Meng Yang, Lequn Li, Ping Wei, Hui Shen et al. · 2019 · Theranostics
12. Liquid biopsy at the frontier of detection, prognosis and progression monitoring in colorectal cancer
    Hui Zhou, Liyong Zhu, Jun Ho Song, Guohui Wang, Pengzhou Li, Weizheng Li, Ping Luo, Xulong Sun, Jin Wu, Yunze Liu et al. · 2022 · Molecular Cancer
13. Cancer Diagnosis: From Tumor to Liquid Biopsy and Beyond
    Ramanathan Vaidyanathan, Ren Hao Soon, Pan Zhang, Kuan Jiang, Chwee Teck Lim · 2018 · Lab on a Chip
14. Droplet-based digital PCR and next generation sequencing for monitoring circulating tumor DNA: a cancer diagnostic perspective
    Mathilde Postel, Alice Roosen, Pierre Laurent‐Puig, Valérie Taly, Shufang Renault · 2017 · Expert Review of Molecular Diagnostics
15. A comprehensive characterization of the cell-free transcriptome reveals tissue- and subtype-specific biomarkers for cancer detection
    Matthew H. Larson, Wenying Pan, Hyunsung John Kim, Ruth E. Mauntz, Sarah M. Stuart, Monica Pimentel, Yiqi Zhou, Per Knudsgaard, Vasiliki Demas, Alexander M. Aravanis et al. · 2021 · Nature Communications
16. Circulating tumor DNA to monitor treatment response in solid tumors and advance precision oncology
    Alexandra Bartolomucci, Monyse de Nóbrega, Sarah Tadhg Ferrier, Kyle Dickinson, Nivedita Kaorey, Amélie Nadeau, A. Castillo, Julia Valdemarin Burnier · 2025 · npj Precision Oncology
17. Diffuse large B-cell lymphoma genotyping on the liquid biopsy
    Davide Rossi, Fary Diop, Elisa Spaccarotella, Sara M. Monti, Manuela Zanni, Silvia Rasi, Clara Deambrogi, Valeria Spina, Alessio Bruscaggin, Chiara Favini et al. · 2017 · Blood
18. Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA
    Jonathan C. Dudley, Joseph G. Schroers‐Martin, Daniel V. Lazzareschi, William T. Shi, Simon Chen, Mohammad Shahrokh Esfahani, Dharati R. Trivedi, Jacob J. Chabon, Aadel A. Chaudhuri, Henning Stehr et al. · 2018 · Cancer Discovery
19. Big data in basic and translational cancer research
    Jiang, Peng, Sinha, Sanju, Aldape, Kenneth, Hannenhalli, Sridhar, Sahinalp, Cenk, Ruppin, Eytan · 2022 · Nature Reviews Cancer
20. Multi-omics approaches for biomarker discovery in early ovarian cancer diagnosis
    Yinan Xiao, Meiyu Bi, Hongyan Guo, Mo Li · 2022 · EBioMedicine
21. Cancer Evolution and the Limits of Predictability in Precision Cancer Medicine
    K. Lipiński, L. Barber, M. Davies, Matthew Ashenden, A. Sottoriva, M. Gerlinger · 2016 · Trends in Cancer
22. White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer
    Alessandro Leal, Nicole C.T. van Grieken, Doreen N. Palsgrove, Jillian A. Phallen, Jamie E. Medina, Carolyn Hruban, Mark A. M. Broeckaert, Valsamo Anagnostou, Vilmos Adleff, Daniel C. Bruhm et al. · 2020 · Nature Communications
23. Bias-Corrected Targeted Next-Generation Sequencing for Rapid, Multiplexed Detection of Actionable Alterations in Cell-Free DNA from Advanced Lung Cancer Patients
    Cloud Peter Paweletz, Adrian Gerold Sacher, Chris K. Raymond, Ryan S. Alden, Allison O’Connell, Stacy L. Mach, Yanan Kuang, Leena Gandhi, Paul T. Kirschmeier, Jessie M. English et al. · 2015 · Clinical Cancer Research
24. Circulating Tumor DNA as Biomarkers for Cancer Detection
    Xiao Han, Junyun Wang, Yingli Sun · 2017 · Genomics Proteomics & Bioinformatics
25. Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction
    David Matthew Kurtz, Mohammad Shahrokh Esfahani, Florian Scherer, Joanne Soo, Michael Chuwei Jin, Chih Long Liu, Aaron M. Newman, Ulrich Dührsen, Andreas Hüttmann, Olivier Casasnovas et al. · 2019 · Cell
26. Longitudinal undetectable molecular residual disease defines potentially cured population in localized non–small cell lung cancer
    Zhang, Jia-Tao, Liu, Si-Yang, Gao, Wei, Liu, Si-Yang Maggie, Yan, Hong-Hong, Ji, Liyan, Chen, Yu, Gong, Yuhua, Lu, Hong-Lian, Lin, Jun-Tao et al. · 2022 · Cancer Discovery
27. Preferred end coordinates and somatic variants as signatures of circulating tumor DNA associated with hepatocellular carcinoma
    Peiyong Jiang, Kun Sun, Yu K. Tong, Suk Hang Cheng, Timothy H.T. Cheng, Macy M. S. Heung, John Wong, Vincent Wai‐Sun Wong, Henry Lik‐Yuen Chan, K. C. Allen Chan et al. · 2018 · Proceedings of the National Academy of Sciences
28. Liquid Biopsy for Cancer: Circulating Tumor Cells, Circulating Free DNA or Exosomes?
    Wei Zhang, Wenjie Xia, Zhengye Lv, Chao Ni, Xin Yin, Liu Yang · 2017 · Cellular Physiology and Biochemistry
29. Inferring gene expression from cell-free DNA fragmentation profiles
    Mohammad Shahrokh Esfahani, Emily G. Hamilton, Mahya Mehrmohamadi, Barzin Y. Nabet, Stefan Alig, Daniel A. King, Chloé Beate Steen, Charles W. Macaulay, André Schultz, Monica C. Nesselbush et al. · 2022 · Nature Biotechnology
30. Liquid Biopsy: Current Status and Future Perspectives
    Sonja Mader, Klaus Pantel · 2017 · Oncology Research and Treatment
31. Circulating Tumor DNA Mutation Profiling by Targeted Next Generation Sequencing Provides Guidance for Personalized Treatments in Multiple Cancer Types
    Yongqian Shu, Xue Wu, Xiaoling Tong, Xiaonan Wang, Zhili Chang, Yu Mao, Xiaofeng Chen, Jing Sun, Zhenxin Wang, Zhuan Hong et al. · 2017 · Scientific Reports
32. Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
    Jason D. Merker, Geoffrey R. Oxnard, Carolyn C. Compton, Maximilian Diehn, Patricia A. Hurley, Alexander J. Lazar, Neal Ian Lindeman, Christina M. Lockwood, Alex J. Rai, Richard L. Schilsky et al. · 2018 · Archives of Pathology & Laboratory Medicine
33. Exosome-Based Detection of EGFR T790M in Plasma from Non–Small Cell Lung Cancer Patients
    Elena Castellanos-Rizaldos, Dominik G. Grimm, Vasisht R. Tadigotla, James D. Hurley, John Healy, Patricia L. Neal, Mia Sher, Raajdeep Venkatesan, Chris Karlovich, Mitch Raponi et al. · 2018 · Clinical Cancer Research
34. The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring
    Syeda Maheen Batool, Anudeep Yekula, Prerna Khanna, Tiffaney Hsia, Austin S. Gamblin, Emil Ekanayake, Ana K. Escobedo, Dong Gil You, Cesar Martin Castro, Hyungsoon Im et al. · 2023 · Cell Reports Medicine
35. Circulating tumor DNA analysis as a real-time method for monitoring tumor burden in melanoma patients undergoing treatment with immune checkpoint blockade
    Evan J. Lipson, Victor E. Velculescu, Theresa S. Pritchard, Mark Sausen, Drew M. Pardoll, Suzanne Louise Topalian, Luis Alberto Diaz · 2014 · Journal for ImmunoTherapy of Cancer
36. Precision medicine in non-small cell lung cancer: Current applications and future directions
    Soo‐Ryum Yang, Anne Maria Schultheis, Helena Alexandra Yu, Diana L. Mandelker, Marc Ladanyi, Reinhard Büttner · 2020 · Seminars in Cancer Biology
37. Future cancer research priorities in the USA: a Lancet Oncology Commission
    Elizabeth M. Jaffee, Chi Van Dang, David B. Agus, Brian Michael Alexander, Kenneth Carl Anderson, Alan Ashworth, Anna D. Barker, Roshan Bastani, Sangeeta N. Bhatia, Jeffrey A. Bluestone et al. · 2017 · The Lancet Oncology
38. A mathematical model of ctDNA shedding predicts tumor detection size
    Stefano Avanzini, David Matthew Kurtz, Jacob J. Chabon, Everett James Moding, Sharon Seiko Hori, Sanjiv Sam Gambhir, Ash A. Alizadeh, Maximilian Diehn, Johannes G. Reiter · 2020 · Science Advances
39. A field guide for cancer diagnostics using cell‐free DNA: From principles to practice and clinical applications
    Anna‐Lena Volckmar, Holger Sültmann, Anja Lisa Riediger, Thoas Fioretos, Peter Schirmacher, Volker Endris, Albrecht Stenzinger, Steffen Dietz · 2017 · Genes Chromosomes and Cancer
40. DNA Clutch Probes for Circulating Tumor DNA Analysis
    Jagotamoy Das, Ivaylo Ivanov, Edward Hartley Sargent, Shana O. Kelley · 2016 · Journal of the American Chemical Society
41. Senescence, Necrosis, and Apoptosis Govern Circulating Cell-free DNA Release Kinetics
    Ariana Rostami, Meghan Lambie, Caberry W. Yu, Vuk Stambolic, John N. Waldron, Scott Victor Bratman · 2020 · Cell Reports
42. ctDNA and CTCs in Liquid Biopsy – Current Status and Where We Need to Progress
    Martin H. Neumann, Sebastian Bender, Thomas Krahn, Thomas Schlange · 2018 · Computational and Structural Biotechnology Journal
43. Machine learning enables detection of early-stage colorectal cancer by whole-genome sequencing of plasma cell-free DNA
    Nathan Wan, David E. Weinberg, Tzu‐Yu Liu, Katherine E. Niehaus, Daniel Delubac, Ajay Kannan, Brandon White, Eric A. Ariazi, Mitch Bailey, Marvin Bertin et al. · 2019 · BMC Cancer
44. Analytical Validation of a Hybrid Capture–Based Next-Generation Sequencing Clinical Assay for Genomic Profiling of Cell-Free Circulating Tumor DNA
    Clark, Travis A., Chung, Jon H., Kennedy, Mark, Hughes, Jason D., Chennagiri, Niru, Lieber, Daniel S., Fendler, Bernard, Young, Lauren, Zhao, Mandy, Coyne, Michael et al. · 2018 · The Journal of Molecular Diagnostics
45. The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation–Positive Non–Small Cell Lung Cancer: Status in 2016
    Tan, Daniel S.W., Yom, Sue S., Tsao, Ming S., Pass, Harvey I., Kelly, Karen, Peled, Nir, Yung, Rex C., Wistuba, Ignacio I., Yatabe, Yasushi, Unger, Michael et al. · 2016 · Journal of Thoracic Oncology
46. Reversion of BRCA1/2 Germline Mutations Detected in Circulating Tumor DNA From Patients With High-Grade Serous Ovarian Cancer
    Elizabeth L. Christie, Sián Fereday, Kenneth Doig, Swetansu Pattnaik, Sarah‐Jane Dawson, David D.L. Bowtell · 2017 · Journal of Clinical Oncology
47. Advanced liquid biopsy technologies for circulating biomarker detection
    Narshone Soda, Bernd H. A. Rehm, Prashant Murlidhar Sonar, Nam‐Trung Nguyen, Muhammad J. A. Shiddiky · 2019 · Journal of Materials Chemistry B
48. Cell-free DNA analysis in current cancer clinical trials: a review
    Mireya Cisneros-Villanueva, Lizbett Hidalgo Pérez, Magdalena Ríos-Romero, Alberto Cedro‐Tanda, C. A. Ruiz-Villavicencio, K. Page, Robert K. Hastings, Daniel Fernández-García, Rebecca C. Allsopp, Marco Antonio Fonseca-Montaño et al. · 2022 · British Journal of Cancer
49. ctDNA monitoring using patient-specific sequencing and integration of variant reads
    Jonathan C. M. Wan, Katrin Heider, Davina Gillian Gale, Suzanne Murphy, Eyal Fisher, Florent C. Mouliere, Andrea Ruiz-Valdepeñas, Ángela Santonja, James Morris, Dineika Chandrananda et al. · 2020 · Science Translational Medicine
50. Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer
    Justin Jee, Emily S. Lebow, Randy Yeh, Jeeban P. Das, Azadeh Namakydoust, Paul K. Paik, Jamie E. Chaft, Gowtham Jayakumaran, Angela Rose Brannon, Ryma Benayed et al. · 2022 · Nature Medicine
51. Reprogramming the immunological microenvironment through radiation and targeting Axl
    Todd Anthony Aguilera, Marjan Rafat, Laura Castellini, Hussein Shehade, Mihalis S. Kariolis, Angela Bik‐Yu Hui, Henning Stehr, Rie von Eyben, Dadi Jiang, Lesley G. Ellies et al. · 2016 · Nature Communications
52. Engineering State‐of‐the‐Art Plasmonic Nanomaterials for SERS‐Based Clinical Liquid Biopsy Applications
    Jing Wang, Kevin M. Koo, Yuling Wang, Matt Trau · 2019 · Advanced Science
53. Monitoring and adapting cancer treatment using circulating tumor DNA kinetics: Current research, opportunities, and challenges
    Enrique Sanz‐García, Eric Y. Stutheit-Zhao, Scott Victor Bratman, Lillian L. Siu · 2022 · Science Advances
54. Identification of Circulating Tumor DNA for the Early Detection of Small-cell Lung Cancer
    Lynnette Fernandez‐Cuesta, Sandra P. Perdomo, Patrice Hodonou Avogbe, Noémie Leblay, Tiffany Myriam Delhomme, Valérie Gaborieau, Behnoush Abedi‐Ardekani, Estelle Chanudet, Magali Olivier, David Georgievich Zaridze et al. · 2016 · EBioMedicine
55. Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA)
    Chin, Re-I, Chen, Kevin, Usmani, Abul, Chua, Chanelle, Harris, Peter K., Binkley, Michael S., Azad, Tej D., Dudley, Jonathan C., Chaudhuri, Aadel A. · 2019 · Molecular Diagnosis & Therapy
56. Clinical application and detection techniques of liquid biopsy in gastric cancer
    Shuo Ma, Meiling Zhou, Yanhua Xu, Xinliang Gu, Mingyuan Zou, Gulinaizhaer Abudushalamu, Yuming Yao, Xiaobo Fan, Guoqiu Wu · 2023 · Molecular Cancer
57. Circulating Tumor DNA Is Effective for the Detection of EGFR Mutation in Non–Small Cell Lung Cancer: A Meta-analysis
    Mantang Qiu, Jie Wang, Youtao Xu, Xiangxiang Ding, Ming Li, Feng Jiang, Lin Xu, Rong H. Yin · 2014 · Cancer Epidemiology Biomarkers & Prevention
58. CancerDetector: ultrasensitive and non-invasive cancer detection at the resolution of individual reads using cell-free DNA methylation sequencing data
    Wenyuan Li, Qingjiao Li, Shuli Kang, Mary Same, Yonggang Zhou, Carol Sun, Chun-Chi Liu, Lea K. Matsuoka, Linda S. Sher, Wing Hung Wong et al. · 2018 · Nucleic Acids Research
59. Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer
    Gideon Michael Blumenthal, Paul A. Bunn, Jamie E. Chaft, Caroline Elizabeth McCoach, Edith A. Perez, Giorgio V. Scagliotti, David Paul Carbone, Hugo J.W.L. Aerts, Dara L. Aisner, Jonas C. S. Bergh et al. · 2018 · Journal of Thoracic Oncology
60. Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications
    Boire, Adrienne, Brandsma, Dieta, Brastianos, Priscilla K, Le Rhun, Emilie, Ahluwalia, Manmeet, Junck, Larry, Glantz, Michael, Groves, Morris D, Lee, Eudocia Q, Lin, Nancy et al. · 2019 · Neuro-Oncology
61. Clinical application of advanced multi-omics tumor profiling: Shaping precision oncology of the future
    Dilara Akhoundova, Mark A. Rubin · 2022 · Cancer Cell
62. Orthogonal Comparison of Four Plasma NGS Tests With Tumor Suggests Technical Factors are a Major Source of Assay Discordance
    Daniel Stetson, Ambar Ahmed, Xing Xu, Barrett R. B. Nuttall, Tristan J. Lubinski, Justin H. Johnson, J. Carl Barrett, Brian Andrew Dougherty · 2019 · JCO Precision Oncology
63. Drug-tolerant persister cells in cancer: the cutting edges and future directions
    Yi Pu, Lu Li, Haoning Peng, Lunxu Liu, Dominique Heymann, Caroline Robert, François M. Vallette, Shensi Shen · 2023 · Nature Reviews Clinical Oncology
64. The Effect of Preservative and Temperature on the Analysis of Circulating Tumor DNA
    Sonya T. Parpart-Li, Bjarne R. Bartlett, Maria Popoli, Vilmos Adleff, Laura Tucker, Rebecca S. Steinberg, Andrew P. Georgiadis, Jill Phallen, Julie Renee Brahmer, Nilo A. Azad et al. · 2016 · Clinical Cancer Research
65. Assessment of EGFR Mutation Status in Matched Plasma and Tumor Tissue of NSCLC Patients from a Phase I Study of Rociletinib (CO-1686)
    Chris Karlovich, Jonathan Wade Goldman, Jong‐Mu Sun, Elaina Mann, Lecia Van Dam Sequist, Krzysztof Konopa, Wei Wen, Philipp Angenendt, Leora Horn, David Robert Spigel et al. · 2016 · Clinical Cancer Research
66. Current and Future Clinical Applications of ctDNA in Immuno-Oncology
    Julia-Christina Stadler, Yassine Belloum, Benjamin Deitert, Mark Sementsov, Isabel Heidrich, Christoffer Gebhardt, Laura Keller, Klaus Pantel · 2021 · Cancer Research
67. Current challenges for detection of circulating tumor cells and cell-free circulating nucleic acids, and their characterization in non-small cell lung carcinoma patients. What is the best blood substrate for personalized medicine?
    Marius Ilié, Véronique Hofman, Élodie Long-Mira, Olivier Bordone, Éric Selva, Kevin Washetine, Charles‐Hugo Marquette, Paul M Hofman · 2014 · PubMed Central
68. Development of a highly sensitive liquid biopsy platform to detect clinically-relevant cancer mutations at low allele fractions in cell-free DNA
    Davina Gillian Gale, Andrew R. J. Lawson, Karen Howarth, Mikidache Madi, Bradley Durham, Sarah Smalley, John D. Calaway, Shannon Blais, Greg Jones, James Clark et al. · 2018 · PLoS ONE
69. Capturing sequence diversity in metagenomes with comprehensive and scalable probe design
    Hayden C. Metsky, Katherine J. Siddle, Adrianne D. Gladden, James Qu, David K. Yang, Patrick Brehio, Andrew Goldfarb, Anne L Piantadosi, Shirlee Wohl, Amber Carter et al. · 2019 · Nature Biotechnology
70. Detection of ubiquitous and heterogeneous mutations in cell-free DNA from patients with early-stage non-small-cell lung cancer
    Mariam Jamal‐Hanjani, Gareth A. Wilson, Stuart D. Horswell, Richard Mitter, Onur Sakarya, Tudor P. Constantin, Raheleh Salari, Eser Kırkızlar, Styrmir Sigurjonsson, Robert J. Pelham et al. · 2016 · Annals of Oncology
71. Circulating Tumor DNA Reveals Clinically Actionable Somatic Genome of Metastatic Bladder Cancer
    Gillian Rae Vandekerkhove, Tilman Todenhöfer, Matti Annala, Werner Jan Struss, Amanda Wong, Kevin Beja, Elie J. Ritch, Sonal Brahmbhatt, Stanislav V. Volik, Jörg Hennenlotter et al. · 2017 · Clinical Cancer Research
72. The potential of liquid biopsies for the early detection of cancer
    Ellen Heitzer, Samantha O. Perakis, Jochen B. Geigl, Michael R. Speicher · 2017 · npj Precision Oncology
73. The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer
    Austin K. Mattox, Christopher Blair Douville, Yuxuan Wang, Maria Popoli, Janine Ptak, Natalie Silliman, Lisa Dobbyn, Joy Schaefer, Steve Lu, Alexander H. Pearlman et al. · 2023 · Cancer Discovery
74. Cancer biomarkers: Written in blood
    Ed Yong · 2014 · Nature
75. Neoadjuvant immunotherapy for non–small cell lung cancer: State of the art
    Jin U. Kang, Chao Zhang, Wen‐Zhao Zhong · 2021 · 癌症：英文版
76. Molecular histology of lung cancer: From targets to treatments
    Steven L. Wood, Maria Pernemalm, Philip A.J. Crosbie, Anthony David Whetton · 2015 · Cancer Treatment Reviews
77. Capture-Based Targeted Ultradeep Sequencing in Paired Tissue and Plasma Samples Demonstrates Differential Subclonal ctDNA-Releasing Capability in Advanced Lung Cancer
    Xiaowei Mao, Zhou Zhang, Xiaoxuan Zheng, Fangfang Xie, Feidie Duan, Liyan Jiang, Shannon Chuai, Han Han‐Zhang, Baohui Han, Jiayuan Sun · 2016 · Journal of Thoracic Oncology
78. Alterations in PTEN and ESR1 promote clinical resistance to alpelisib plus aromatase inhibitors
    Pedram Razavi, Maura N. Dickler, Payal Deepak Shah, Weiyi Toy, David N. Brown, Helen H. Won, Bob T. Li, Ronglai Shen, Neil Vasan, Shanu Modi et al. · 2020 · Nature Cancer
79. Liquid biopsy techniques and lung cancer: diagnosis, monitoring and evaluation
    Fei Ren, Qian Fei, Kun Liang Qiu, Yuanjie Zhang, Heyang Zhang, Lei Sun · 2024 · Journal of Experimental & Clinical Cancer Research
80. Molecular biomarkers for lung adenocarcinoma
    Olivier Calvayrac, Anne Pradines, Elvire Pons Tostivint, Julien Mazières, Nicolas Marie Guibert · 2017 · European Respiratory Journal
81. Circulating tumor cells and circulating tumor DNA for precision medicine: dream or reality?
    Michail Ignatiadis, Sarah‐Jane Dawson · 2014 · Annals of Oncology
82. Tumor circulome in the liquid biopsies for cancer diagnosis and prognosis
    Jicheng Wu, Shen Hu, Lihong Zhang, Jinxia Xin, Chongran Sun, Liquan Wang, Kefeng Ding, Ben Wang · 2020 · Theranostics
83. Circulating cell-free DNA for cancer early detection
    Qiang Gao, Qiang Zeng, Zhijie Wang, Chengcheng Li, Yu Xu, Peng Cui, Zhu Xin, Huafei Lu, Guoqiang Wang, Shangli Cai et al. · 2022 · The Innovation
84. Accessing Genetic Information with Liquid Biopsies
    Xuyu Cai, Filip Jankú, Qimin Zhan, Jian‐Bing Fan · 2015 · Trends in Genetics
85. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients
    Laure Sorber, Karen Zwaenepoel, Vanessa Deschoolmeester, Paul E. Van Schil, Jan P. van Meerbeeck, Filip Lardon, Christian Diego Rolfo, Patrick Pauwels · 2016 · Lung Cancer
86. Clinical relevance of circulating KRAS mutated DNA in plasma from patients with advanced pancreatic cancer
    Kjersti Tjensvoll, Morten Lapin, Tove Buhl, Satu Oltedal, Katrine Steen-Ottosen Berry, Bjørnar Gilje, Jon Arne Søreide, M. M. Javle, Oddmund Nordgård, Rune Smaaland · 2015 · Molecular Oncology
87. Ultra-deep next-generation sequencing of plasma cell-free DNA in patients with advanced lung cancers: results from the Actionable Genome Consortium
    B.T. Li, Filip Jankú, Birte Kristin Jung, C. Hou, Kiran Madwani, Ryan S. Alden, Pedram Razavi, Jorge Sergio Reis-Filho, Ronglai Shen, James M. Isbell et al. · 2019 · Annals of Oncology
88. Clinical utility of circulating tumor DNA for colorectal cancer
    Hiroki Osumi, Eiji Shinozaki, Kensei Yamaguchi, Hitoshi Zembutsu · 2019 · Cancer Science
89. Pattern recognition for predictive, preventive, and personalized medicine in cancer
    Tingting Cheng, Xianquan Zhan · 2017 · The EPMA Journal
90. The liquid biopsy in the management of colorectal cancer patients: Current applications and future scenarios
    Nicola Normanno, Andrès M.R. Cervantes, Fortunato Ciardiello, Antonella De Luca, Carmine Pinto · 2018 · Cancer Treatment Reviews
91. Advances in computational approaches for prioritizing driver mutations and significantly mutated genes in cancer genomes
    Feixiong Cheng, Junfei Zhao, Zhongming Zhao · 2015 · Briefings in Bioinformatics
92. Whole-Exome Sequencing of Cell-Free DNA Reveals Temporo-spatial Heterogeneity and Identifies Treatment-Resistant Clones in Neuroblastoma
    Mathieu Chicard, Leo Colmet Daage, Nathalie Clément, Adrien Danzon, Mylène Bohec, Virginie Bernard, Sylvain Baulande, Angela Bellini, Paul Deveau, Gaëlle Pierron et al. · 2017 · Clinical Cancer Research
93. ESR/ERS statement paper on lung cancer screening
    on behalf of the European Society of Radiology (ESR) and the European Respiratory Society (ERS), Hans‐Ulrich Kauczor, Anne‐Marie Baird, Torsten Gerriet Blum, Lorenzo Bonomo, Clementine Bostantzoglou, Otto Chris Burghuber, Blanka Čepická, Alina Comanescu, S. Couraud et al. · 2020 · European Radiology
94. Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma
    Xiaolin Wu, Jiahui Li, Asmae Gassa, Denise Buchner, Hakan Alakus, Qiongzhu Dong, Ning Ren, Ming Liu, Margarete Odenthal, Dirk Ludger Stippel et al. · 2020 · International Journal of Biological Sciences
95. Early ctDNA dynamics as a surrogate for progression-free survival in advanced breast cancer in the BEECH trial
    Sarah Hrebien, Valentina Citi, Isaac García-Murillas, Ros Cutts, Kerry Fenwick, Iwanka Kozarewa, Robert K. McEwen, Jayantha Ratnayake, Rhiannon Maudsley, Thomas Hedley Carr et al. · 2019 · Annals of Oncology
96. A Study of Hypermethylated Circulating Tumor DNA as a Universal Colorectal Cancer Biomarker
    Sonia Garrigou, Géraldine Perkins, Fanny Garlan, Corinne Normand, Audrey Didelot, Delphine Le Corre, Sanam Peyvandi, Claire Mulot, Ralph Niarra, Pascaline Aucouturier et al. · 2016 · Clinical Chemistry
97. Clinical validity of saliva and novel technology for cancer detection
    Karolina Elżbieta Kaczor‐Urbanowicz, Wei Fang, Shannon Liu Rao, Jinseok Kim, Heebum Shin, Jordan C. Cheng, Michael Kai Tu, David T. Wong, Yong H. Kim · 2019 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
98. Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma.
    S. Assouline, T. H. Nielsen, Stephen L. Yu, M. Alcaide, Lauren Chong, D. Macdonald, A. Tosikyan, V. Kukreti, A. Kezouh, Tina Petrogiannis-Haliotis et al. · 2016 · Blood
99. Detection of Somatic Structural Variants Enables Quantification and Characterization of Circulating Tumor DNA in Children With Solid Tumors
    Kelly S. Klega, Alma Imamović, Gavin Ha, Andrea N. Clapp, Stephanie C. Meyer, Abigail Ward, Catherine Clinton, Anwesha Nag, Eliezer M. Van Allen, Elizabeth Anne Mullen et al. · 2018 · JCO Precision Oncology
100. Detection of Minimal Residual Disease Using ctDNA in Lung Cancer: Current Evidence and Future Directions
     Young Kwang Chae, Michael S. Oh · 2018 · Journal of Thoracic Oncology